We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERY
3901
DELISTED
Vericity, Inc. Common Stock
VERY
$226K ﹤0.01%
19,869
+325
+2% +$3.68K
CVU icon
3902
CPI Aerostructures
CVU
$68.5M
$224K ﹤0.01%
95,790
+1,527
+2% +$3.96K
CCAP icon
3903
Crescent Capital BDC
CCAP
$434M
$222K ﹤0.01%
12,883
CYTH
3904
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$222K ﹤0.01%
159,749
+7,672
+5% +$12.7K
BKTI icon
3905
BK Technologies
BKTI
$291M
$222K ﹤0.01%
15,206
+305
+2% +$3.78K
ABP
3906
DELISTED
Abpro Holdings
ABP
$222K ﹤0.01%
690
RWAY icon
3907
Runway Growth Finance
RWAY
$287M
$221K ﹤0.01%
18,253
PTN
3908
Palatin Technologies
PTN
$13.8M
$221K ﹤0.01%
2,363
+480
+25% +$70.4K
FLNT
3909
Fluent
FLNT
$120M
$221K ﹤0.01%
74,686
UBX
3910
DELISTED
Unity Biotechnology
UBX
$220K ﹤0.01%
134,133
+2,351
+2% +$4.08K
BIOR
3911
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$219K ﹤0.01%
19,925
+10,621
+114% +$115K
RFIL icon
3912
RF Industries
RFIL
$139M
$219K ﹤0.01%
70,470
NTWK icon
3913
NetSol Technologies
NTWK
$50.6M
$218K ﹤0.01%
78,741
EMKR
3914
DELISTED
Emcore Corp
EMKR
$218K ﹤0.01%
63,191
+6,049
+11% +$28.6K
DALN
3915
DELISTED
DallasNews
DALN
$218K ﹤0.01%
56,985
DMTK
3916
DELISTED
DermTech, Inc. Common Stock
DMTK
$217K ﹤0.01%
308,736
+8,462
+3% +$9.56K
ONCT
3917
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$217K ﹤0.01%
+24,079
New +$212K
FAAS
3918
DELISTED
DigiAsia
FAAS
$217K ﹤0.01%
24,315
+554
+2% +$5.3K
CDIO icon
3919
Cardio Diagnostics
CDIO
$5.3M
$216K ﹤0.01%
5,076
+462
+10% +$26.3K
CLRO icon
3920
ClearOne Inc
CLRO
$27.2M
$215K ﹤0.01%
7,824
GRVY
3921
GRAVITY
GRVY
$473M
$213K ﹤0.01%
+2,811
New +$197K
NTIP icon
3922
Network-1 Technologies
NTIP
$36.4M
$213K ﹤0.01%
102,666
AWRE icon
3923
Aware
AWRE
$27.7M
$212K ﹤0.01%
113,449
+2,386
+2% +$4.16K
TRIN icon
3924
Trinity Capital Inc.
TRIN
$1.71B
$212K ﹤0.01%
14,443
HNNA icon
3925
Hennessy Advisors
HNNA
$78.5M
$212K ﹤0.01%
30,692
+607
+2% +$4.16K

Similar funds

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.